Ruxolitinib + Allogeneic Stem Cell Transplantation in AML
Ruxolitinib + Allogeneic Stem Cell Transplantation in AML
Active, not recruiting · NCT03286530 · Registry updated 2026-03-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ruxolitinib + Allogeneic Stem Cell Transplantation in AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 2 | 2026-03-27 | NCT03286530 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Massachusetts General Hospital | 758 |
| Medical College of Wisconsin | 201 |
| Ohio State University | 297 |
| Vanderbilt University | 62 |
| Washington University School of Medicine | 475 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beth Israel Deaconess Medical Center | Boston | United States | 45 |
| Massachusetts General Hospital | Boston | United States | 39 |
| Medical College of Wisconsin | Wauwatosa | United States | 4 |
| The Ohio State University | Columbus | United States | 191 |
| Vanderbilt University | Nashville | United States | 16 |
| Washington University | St Louis | United States | 34 |